PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026Vascular and Endovascular Surgery0 citations

Comparative Outcomes of Carotid Endarterectomy and Carotid Artery Stenting: A Single-Center Experience

View Full Paper
MÇMuhammet Cihat ÇelikAÇAyla Ece ÇeliktenADAbdullah Kadir Dolu

Key Points

  • This research aims to compare the safety and efficacy of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in patients with carotid stenosis.
  • Retrospective analysis of 202 patients undergoing carotid revascularization from October 2016 to April 2025.
  • Divided patients into two groups: CEA (67 patients) and CAS (135 patients).
  • Evaluated outcomes for stroke, myocardial infarction (MI), and all-cause mortality at 30 days, 1 year, and 3 years.
  • Periprocedural stroke rates were 4.5% for CEA and 2.2% for CAS.
  • 1-year MI rates were significantly higher after CEA (8.6%) compared to CAS (1.5%).
  • At 3 years, stroke and MI rates were numerically higher in the CEA group but not statistically significant.

Abstract

Background Carotid endarterectomy (CEA) is recommended as the standard revascularization strategy for patients with carotid stenosis, whereas carotid artery stenting (CAS) is generally reserved for high-risk surgical candidates. However, evidence comparing the safety and efficacy of both approaches in real-world practice remains heterogeneous. Methods We retrospectively analyzed 202 patients (mean age: 71.1 ± 8.5 years; 152 males, 75.2%) who underwent carotid revascularization at a single center between October 2016 and April 2025. Patients with symptomatic moderate-to-severe stenosis (50-99%) and asymptomatic severe stenosis (70-99%) were included. Based on the revascularization strategy, patients were divided into CEA (n = 67) and CAS (n = 135) groups. Periprocedural (30-day), 1 and 3-year outcomes including stroke, myocardial infarction (MI), and all-cause mortality were evaluated. Results Among patients, periprocedural stroke occurred in 4.5% of CEA patients and 2.2% of CAS patients ( P = 0.653), MI in 1.5% and 0%, ( P = 0.720), and all-cause mortality in 4.5% and 0.7% ( P = 0.208) respectively. At 1-year follow-up, MI was significantly more frequent after CEA compared with CAS (8.6% vs 1.5%, P = 0.029), whereas stroke (8.6% vs 5.3%, P = 0.387) and all-cause mortality (10.3% vs 12.9%, P = 0.622) did not differ significantly. At 3 years, rates of stroke (12.3% vs 5.3%), MI (10.3% vs 3.8%), and all-cause mortality (22.4% vs 15.9%) were numerically higher in the CEA group, although these differences were not statistically significant. Subgroup analyses according to symptomatic status demonstrated no significant differences in 30-day, 1 or 3-year rates of stroke, MI, or all-cause mortality between the CEA and CAS groups. Conclusion In this single-center experience, CAS achieved peri-procedural and short-term outcomes comparable to CEA, despite being performed in a more frail and comorbid patient population. These findings suggest that CAS may represent a safe and effective alternative to CEA in high-risk surgical candidates when performed by experienced operators within a multidisciplinary framework.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Çelik et al. (2026) studied this question.

synapsesocial.com/papers/698829520fc35cd7a88498b6https://doi.org/10.1177/15385744261423761
Ask AI
Helpful
Bookmark
Share
View Full Paper